Top Abstract Purchase Related
Home
>
Node
>
Subnode

Malakoplakia in renal transplantation: an expression of altered tissue reactivity under immunosuppression

Shabtai, M.; Anaise, D.; Frei, L.; Waltzer, W.C.; Frischer, Z.I.; Jao, S.; Miller, F.; Rapaport, F.T.

Transplantation Proceedings 21(4): 3725-3727

1989

ISSN/ISBN: 0041-1345
PMID: 2669285
Document Number: 334833
This report describes the successful treatment in a transplant recipient of a case of MK originating from the native urinary tract. As demonstrated, MK may pursue unexpected patterns to which conventional therapeutic guidelines may not be applicable. The type of surgical intervention used must be dictated by the extent and location of the disease and its complications. Withdrawal of immunosuppressive medication was useful in improving the patient's prognosis.

Document emailed within 1 workday
Secure & encrypted payments

MacMillan, R.D.; Cardella, C.J.; Crawford, L.; Biggar, W.D. 1982: Malakoplakia following renal transplantation Transplantation Proceedings 14(4): 700-701
Kamińrska, D.; Tyran, B.; Mazanowska, O.; Rabczyński, J.; Patrzałek, D.; Szyber, P.; Chudoba, P.ł; Klinger, M. 2006: Gene expression of INF-gamma, IL-10, IL-2, IL-6, PDGF-B i TGF-beta in kidney tissue after renal transplantation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(122): 148-150; Discussion 151
Kawaguchi, H.; Komatsu, Y.; Hattori, M.; Nagata, M.; Ito, K.; Takahashi, K.; Teraoka, S.; Toma, H.; Ota, K. 1989: Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan Transplantation Proceedings 21(1 Part 2): 1698-1700
Bonomini, V.; Scolari, M.P.; Buscaroli, A.; Liviano D'Arcangelo, G.; Stefoni, S. 1997: Immunosuppression in renal transplantation International Journal of Artificial Organs 20(2): 73-75
Tanabe, K.; Koga, S.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Babazono, T.; Yagisawa, T.; Toma, H.; Kawai, T.; Fuchinoue, S.; Teraoka, S.; Ota, K. 1996: Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression Transplantation Proceedings 28(3): 1304-1305
Raine, A.E.; Carter, R.; Mann, J.I.; Chapman, J.R.; Morris, P.J. 1987: Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression Transplantation Proceedings 19(1 Part 2): 1820-1821
Morris-Stiff, G.; Khan, A.; Quiroga, I.; Baboo, R.; Jurewicz, W.A. 1999: Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies Bmj 319(7217): 1136; Author Reply 1137
Tax, W.J.; van de Heijden, H.M.; Willems, H.W.; Hoitsma, A.J.; Berden, J.H.; Capel, P.J.; Koene, R.A. 1987: Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation Transplantation Proceedings 19(1 Part 3): 1905-1907
Schweizer, R.T.; Bow, L.; Roper, L.; Hull, D.; Bartus, S.A. 1988: Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression Clinical Transplants 1988: 147-158
Odocha, O.; McCauley, J.; Scantlebury, V.; Shapiro, R.; Carroll, P.; Jordan, M.; Vivas, C.; Fung, J.J.; Starzl, T.E. 1993: Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression Transplantation Proceedings 25(4): 2433-2434
Andreu, J.; Campistol, J.M.; Oppenheimer, F.; Torregrosa, V.; Ricart, M.J.; Vilardell, J.; Carretero, P. 1994: Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience Transplantation Proceedings 26(1): 337-340
Tinti, F.; Mitterhofer, A.P.; Muiesan, P. 2012: Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors Minerva Chirurgica 67(1): 1-13
Norman, D.J.; Barry, J.M.; Bennett, W.M.; Munson, J.L.; Meyer, M.; Henell, K.; Kimball, J.; Hubert, B. 1991: OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses Transplantation Proceedings 23(1 Part 2): 1052-1054
Rao, K.V.; Andersen, R.C. 1989: The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation Transplantation Proceedings 21(1 Part 2): 1652
Goffin, E.; Devogelaer, J.P.; Depresseux, G.; Squifflet, J.P.; Pirson, Y.; van Yperselede de Strihou, C. 2003: Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study Clinical Nephrology 59(3): 190-195
Tsai, M.-K.; Hu, R.-H.; Lee, C.-J.; Lee, P.-H. 2002: Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression Journal of the Formosan Medical Association 101(9): 616-621
López Pérez, A.; Cuevas Ruiz, C. 1990: Unusual association of malakoplakia and renal polycystosis. A case report Archivos Espanoles de Urologia 43(7): 788-792
Oliver, R.T.; Sachs, J.A.; Festenstein, H. 1973: A collaborative scheme for tissue typing and matching in renal transplantation. VI. Clinical relevance of HL-A matching in 349 cadaver renal transplants Transplantation Proceedings 5(1): 245-251
Yousif, M.; Abbas, Z.; Mubarak, M. 2006: Rectal malakoplakia presenting as a mass and fistulous tract in a renal transplant patient Jpma. Journal of the Pakistan Medical Association 56(8): 383-385
Hökl, J.; Cerný, J.; Nĕmec, P. 1995: Advances in transplantation biology and transplantation of vital organs in the era of immunosuppression with cyclosporin a Casopis Lekaru Ceskych 134(24): 775-778